Pharmaceuticals, Biotechnology and Life Sciences
The combined company will operate as “Oruka Therapeutics, Inc.” with its common stock traded on Nasdaq under trading symbol “ORKA”…
SEATTLE, Aug. 29, 2024 (GLOBE NEWSWIRE) — Umoja Biopharma, Inc. (Umoja), a transformative immunotherapy company creating off-the-shelf treatments that aim…
Vancouver, Canada, Aug. 29, 2024 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the “Company”), a…
TEL AVIV, Israel, Aug. 29, 2024 (GLOBE NEWSWIRE) — SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), a specialty clinical-stage pharmaceutical…
Company Realizes $10.4M Gain on the Sale of STEMWINNIPEG, Manitoba, Aug. 29, 2024 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX-…
SEATTLE, Aug. 29, 2024 (GLOBE NEWSWIRE) — Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for…
Strong balance sheet with successful completion of upsized $179.0 million initial public offering Treatment initiated in the first patient in…
SAN DIEGO, Aug. 29, 2024 (GLOBE NEWSWIRE) — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on…
Potential first product approval and preparing for commercial launchNEW YORK, Aug. 28, 2024 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB),…
WESTMINSTER, Colo., Aug. 26, 2024 (GLOBE NEWSWIRE) — ARCA biopharma, Inc. (NASDAQ: ABIO) (“ARCA”) today announced an update to the…